Research spans bioanalytical assay development and immunogenicity assessment, pathogen drug-tolerance mechanisms, and CNS-targeted delivery. Emphasis on validating biomarker/antibody assays, resolving neuroinflammation, and engineering nanoparticle and amphiphilic vesicle systems that cross the blood–brain barrier.